Study of TQF3250 capsules for type 2 diabetes with overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests a new capsule medicine for adults with type 2 diabetes who are overweight or have obesity. The goal is to see if it helps control blood sugar and weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to provide signed consent and be willing to follow the study plan, including diet and exercise.
- You must be 18 to 70 years old.
- You must be diagnosed with type 2 diabetes and also have overweight or obesity.
- You must not have other types of diabetes or complications from diabetes that need urgent care.
- You haven't had uncontrolled heart, liver, kidney, or other serious health problems recently.
- Women who can get pregnant and men must agree to use effective birth control during the trial and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication (TQF3250) in healthy adults to see how safe it is and how the body processes it. If you are a generally healthy Chinese volunteer, you may be able to help researchers learn about this potential treatment.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Hear when a new Type 2 Diabetes Mellitus Combined With Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.